Clinical Studies: 2005 Start Date

Psoriasis
Sponsor: Abbott Laboratories
A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of Subcutaneous Injections of XXXXX vs. Placebo in Subjects with Moderate to Severe Chronic Plaque Psoriasis.
December 2005 to 2008

Psoriasis
Sponsor: Astellas Pharma US, Inc.
A Phase III, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of BID Application of XXXXX versus Cream Vehicle in the Treatment of Psoriasis.
September 2005 to April 2007

Actinic Keratosis
Sponsor: 3M Pharmaceuticals
A Phase IV Open-Label Safety and Pharmacokinetic Study of XXXXX for One, Two, Or Three Treatment Cycles to Surface Areas Greater than 25cm² with Actinic Keratosis.
September 2005 to June 2007

Clinical Studies